Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration

scientific article published on 01 February 1993

Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1378/CHEST.103.2.508
P698PubMed publication ID8432145

P2093author name stringJ M Belsh
P L Schiffman
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectamyotrophic lateral sclerosisQ206901
P304page(s)508-513
P577publication date1993-02-01
P1433published inChestQ5093377
P1476titlePulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration
P478volume103

Reverse relations

cites work (P2860)
Q53198631A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland.
Q36075065Assessment of disease progression in motor neuron disease
Q90534110Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols
Q48758870Bipap improves survival and rate of pulmonary function decline in patients with ALS.
Q30446869Bulbar and speech motor assessment in ALS: challenges and future directions.
Q33867342Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS.
Q92016936Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis
Q35501852Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
Q62394038Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS)
Q28596787Diaphragm pacing and motor neurone disease: lessons for all?
Q64118994Diaphragmatic Neurophysiology and Respiratory Markers in ALS
Q47652452Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
Q33545071Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease
Q51801549Evaluation of sham non-invasive ventilation for randomized, controlled trials in ALS.
Q36143045Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population
Q73819705H-reflex changes in the course of amyotrophic lateral sclerosis
Q35058671Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice
Q92863328Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model
Q74841363Long-term mechanical ventilation in amyotrophic lateral sclerosis
Q64087673Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
Q34530167Management of motor neurone disease
Q34649259Outcome of ventilatory support for acute respiratory failure in motor neurone disease
Q90449530Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation
Q55004580Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
Q33694106Practice parameter: The care of the patient with amyotrophic lateral sclerosis (An evidence-based review).
Q30407658Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach
Q36447824Prognostic factors in ALS: A critical review
Q73128601Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol
Q34490602Pulmonary function testing in neuromuscular disease
Q34558955Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival
Q35449456Respiratory aspects of neurological disease
Q33745573Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies.
Q37307518Respiratory training in an individual with amyotrophic lateral sclerosis
Q73321343Series 4: respiratory muscles in neuromuscular diseases and the chest cavity. The function of respiratory muscles in neuromuscular diseases
Q37234667Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4.
Q37976297Sleep-disordered breathing in neurodegenerative diseases
Q43828824Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis
Q92360470The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia
Q24813305The cost-effectiveness of early noninvasive ventilation for ALS patients.
Q34523766Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study
Q81797022[Management and treatment of respiratory failure associated with amyotrophic lateral sclerosis]
Q83060840[Neuromuscular disorders - assessment of the respiratory muscles]
Q79805898[Review of nutritional and respiratory support in ALS]

Search more.